Gubra A/S raised financial guidance for full-year 2023. For the period, organic revenue growth is now expected to be 16-21% (previously around 10%).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
333 DKK | -2.63% | +2.15% | +166.40% |
May. 07 | Gubra A/S Announces Management Changes | CI |
Apr. 17 | Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss | CI |
1st Jan change | Capi. | |
---|---|---|
+166.40% | 802M | |
+17.97% | 125B | |
+13.91% | 108B | |
-6.89% | 23.64B | |
+2.39% | 22.39B | |
-12.11% | 17.78B | |
-41.64% | 16.43B | |
-15.54% | 16.34B | |
+0.24% | 13.56B | |
+24.43% | 11.59B |
- Stock Market
- Equities
- GUBRA Stock
- News Gubra A/S
- Gubra A/S Raises Financial Guidance for Full-Year 2023